| Category | The total number of examined | The total number of positive | Prevalence (%) |
| At Camel level |
|
|
|
| Clinical | 96 | 5 | 5.2% |
| Subclinical | 96 | 28 | 29.2% |
| Overall | 96 | 33 | 34.4% |
| At Quarter level |
|
|
|
| Clinical | 384 | 18 | 4.7% |
| Subclinical | 384 | 160 | 41.6% |
| Overall | 384 | 178 | 46.3% |